>Marché des médicaments contre le pinguéculum en Asie-Pacifique, par traitement (larmes artificielles/ lubrifiants topiques , gouttes ophtalmiques stéroïdiennes, gouttes anti-inflammatoires non stéroïdiennes et autres), type de formulation (gouttes ophtalmiques, pommades ophtalmiques et autres), mode d'achat (sur ordonnance, en vente libre (OTC)), type de médicament (de marque et génériques), type de population (gériatrique et adultes), utilisateur final (hôpitaux, cliniques spécialisées, soins à domicile et autres), canal de distribution (pharmacies hospitalières, pharmacies de détail, pharmacies en ligne et autres) - Tendances et prévisions de l'industrie jusqu'en 2029.
Analyse et perspectives du marché des médicaments contre le pinguéculum en Asie-Pacifique
Le pinguéculum est une excroissance conjonctivale typique qui n'est pas maligne. Les facteurs de risque de progression du pinguécula comprennent l'exposition aux rayons ultraviolets, les traumatismes, le vent, la poussière et le sable, le travail en extérieur pendant une longue durée et l'âge avancé.
Le rapport sur le marché des médicaments contre le pinguéculum en Asie-Pacifique fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et localisé, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste. Notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Data Bridge Market Research analyse que le marché des médicaments contre le pinguéculum en Asie-Pacifique connaîtra un TCAC de 8,5 % au cours de la période de prévision de 2022 à 2029.
|
Rapport métrique |
Détails |
|
Période de prévision |
2022 à 2029 |
|
Année de base |
2021 |
|
Années historiques |
2020 (Customisale jusqu'en 2014-2019) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, prix en USD |
|
Segments couverts |
Par traitement (larmes artificielles/lubrifiants topiques, gouttes ophtalmiques stéroïdiennes, gouttes anti-inflammatoires non stéroïdiennes et autres), type de formulation (gouttes ophtalmiques, pommades ophtalmiques et autres), mode d'achat (sur ordonnance, en vente libre (OTC)), type de médicament (de marque et génériques), type de population (gériatrie et adultes), utilisateur final (hôpitaux, cliniques spécialisées, soins à domicile et autres), canal de distribution (pharmacies hospitalières, pharmacies de détail, pharmacies en ligne et autres) |
|
Pays couverts |
Chine, Japon, Corée du Sud, Inde, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, Vietnam et reste de l'Asie-Pacifique |
|
Acteurs du marché couverts |
AbbVie Inc., Amneal Pharmaceuticals LLC., Spectra Vision Care, SAGER PHARMA, Maya Biotech Private Limited, Novartis AG, Akorn Operating Company LLC, Théa Laboratories, OASIS Medical, Similasan Corporation, Bausch & Lomb Incorporated, Prestige Consumer Healthcare, Inc., Alcon Inc., Wellona Pharma, Johnson & Johnson Vision Care, Inc., EYERIS VISIONCARE Pvt. Ltd., Sylentis , Zydus Group, Bayer AG, Santen Pharmaceutical Co., Ltd |
Définition du marché
A pingueculum is a typical conjunctival growth that is not malignant. This is the transparent, delicate tissue that encircles the eye's white region (sclera). Pinguecula word is derived from the Latin word pinguis, which means "fat" or "grease." The growth occurs in the part of the conjunctiva that is exposed when the eye is open. The risk factors for the progression of pinguecula include exposure to ultraviolet light, trauma, wind, dust and sand, working outdoors for a long duration and advancing age. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could simply be due to a higher rate of UV exposure. It appears as a tiny, yellowish bump on the conjunctiva close to the cornea. It may emerge on either side of the cornea.
Asia-Pacific Pingueculum Drugs Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below
- Rising prevalence of pinguecula disorders and ocular pains
In 2020, according to the published article "Prevalence and associated factors of pinguecula in Western Turkey" by ULAKBİM Journal Systems, the study included 1443 individuals over the age of 20 years of Western Turkey, where it was found that 52.5% of people had pinguecula and out of that 52.5%, the prevalence of pinguecula was higher in males (58.4%), as compared to females (46.8%).
The prevalence of pinguecula disease keeps showing a surge in growth as several environmental and external factors worldwide. Chemical burns and flash burns cause significant and severe ocular pain due to irritations over the eye surface. Thus, the rising prevalence of pinguecula disorder and ocular pain is expected to drive the Asia-Pacific pingueculum drugs market in the forecast period.
- Rise in chronic UV radiation exposure due to ozone defect
In 2019, according to the published journal by "the Association for Research in Vision and Ophthalmology," it was stated that early pinguecula was found to have a prevalence of 39.5% in the temporal conjunctiva and 43.9% in the nasal conjunctiva respectively. That the reported amount of time spent on outdoor activities was 19.6% and 16.1% for less than 2 hours, 44.7% and 52.2% for 4 to 6 hours, respectively and 75.0% in both fields for more than 6 hours, indicates a positive correlation between the prevalence of pinguecula and the amount of time spent on outdoor activities and UV radiation exposure.
There is a correlation between increased exposure to UV and a higher prevalence of pinguecula. This demonstrates that there is a connection between the prevalence of pinguecula and exposure to sunlight. The ozone layer defect is also leading to an increase in the exposure of UV exposure which is increasing the prevalence of pinguecula disorder. Thus, it is expected to drive The Asia-Pacific pingueculum drugs market growth.
- Initiatives and plans to lessen the prevalence of eye illnesses
In 2020, The VISION 2020: The Right to Sight initiative was introduced in 1999 by the World Health Organization (WHO), Geneva, Switzerland and the International Agency for the Prevention of Blindness (IAPB), London, England. The Europe initiative VISION2020 seeks to end avoidable blindness by 2020 and focuses on the main causes of avoidable visual impairment.
According to the article by CDC (Centres for disease control and prevention), in 2022, through Vision Health Initiative (VHI) and diverse stakeholders, CDC initiated a coordinated national public health framework to prevent blindness and vision impairment.
The initiatives and plans are working as an opportunity for the market. Hence, initiatives and plans to lessen the prevalence of eye illness are expected to act as an opportunity for the growth of the Asia-Pacific pingueculum drugs market.
Restraints/Challenges
- Adverse effects of steroid eye drops
Ophthalmologists or optometrists are recommended by patients with mild to severe pinguecula for a thorough examination and prompt treatment. Most often, local tropical steroids, tropical immune modulators, lubricating ointment, gel, or drops are used to treat them.
Prednisolone is the topical steroid that is most frequently used to treat ocular pain. The prednisolone acetate ophthalmic suspension has below mentioned common adverse effects:
- Eyes sting, burn, or itch for one to two minutes after using this medicine
- Vision temporarily obscured
- Increased light sensitivity
- Visual alterations
- Experiencing a foreign object in your eyes
- Allergic responses
Lack of healthcare facilities for eye treatment
As per IntechOpen 2020 report, the prevalence of blindness and ocular disorders in high-income countries is 0.3 per 1000 people, but in low-income countries, the estimation is 1.5 per 1000. This shows the unmet need for ophthalmology care in low-income countries
Another major problem in low-income countries is the lack of awareness regarding ocular pain and other disorders. Many research studies report the high requirement of low-income countries for eye health care and their unmet needs are still gaining attention among many healthcare organizations. Hence, the poor healthcare facility for eye treatments in low and middle-income countries may act as restraints for the growth of the Asia-Pacific pingueculum drugs market.
Post-COVID-19 Impact on the Asia-Pacific Pingueculum Drugs Market
COVID-19 has negatively affected the market. Lockdowns and isolation during the pandemic complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.
Recent Development
- In May 2022, Alcon announced the acquisition of EYSUVIS (loteprednol etabonate suspension) pharmaceutical eye drop from Kala Pharmaceuticals, Inc. The acquisition will complement the company's Systane family of eye drops which includes preservative-free formulations, among others
- In September 2022, Johnson & Johnson Vision Care, Inc. announced the launch of its new innovation of Acuvue Oasys Max–day contact lenses and its multifocal contact lenses for presbyopia. Additionally, these new contact lenses are with the new technology to meet the digitally intense lifestyle
Asia-Pacific Pingueculum Drugs Market Scope
Asia-Pacific pingueculum drugs market is categorized into seven notable segments based on drug type, treatment, formulation, mode of purchase, population type, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Artificial Tears/Topical Lubricants
- Steroid Eye Drops
- Non-steroidal Eye Drops
- Others
Based on treatment, the Asia-Pacific pingueculum drugs market is segmented into artificial tears/topical lubricants, steroid eye drops, non-steroidal eye drops and others.
Formulation Type
- Eye Drops
- Eye Ointments
- Others
Based on formulation, the Asia-Pacific pingueculum drugs market is segmented into eye drops, eye ointments and others.
Mode of Purchase
- Prescription
- Over the Counter (OTC)
Based on mode of purchase, the Asia-Pacific pingueculum drugs market is segmented into prescription and over the counter (OTC).
Drug Type
- Branded
- Generics
Based on population type, the Asia-Pacific pingueculum drugs market is segmented into branded and generics.
Population Type
- Geriatric
- Adults
Based on population type, the Asia-Pacific pingueculum drugs market is segmented into geriatric and adults.
End User
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others
Based on end user, the Asia-Pacific pingueculum drugs market is segmented into hospitals, specialty clinics, home healthcare and others.
Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
Based on the distribution channel, the Asia-Pacific pingueculum drugs market is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.
Pingueculum Drug Market Regional Analysis/Insights
Asia-Pacific pingueculum drugs market is analyzed and market size insights and trends are provided by country, drug type, treatment, formulation, mode of purchase, population type, end user and distribution channel as referenced above.
The countries covered in the Asia-Pacific pingueculum drugs market report are China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific.
China is expected to dominate the Asia-Pacific pingueculum drugs because of initiatives and plans to lessen the prevalence of eye illness. The Asia-Pacific pingueculum drugs market is expected to grow due to the increasing prevalence of pingueculum in tropical areas and the growing geriatric population.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Asia-Pacific brands and the challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Pingueculum Drugs Market Share Analysis
Asia-Pacific pingueculum drugs market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to Asia-Pacific pingueculum drugs market.
Some of the major players operating in the Asia-Pacific pingueculum drugs market are Alcon Inc., Johnson & Johnson Services, Inc., Novartis AG, Akorn Operating Company LLC, Bausch & Lomb Incorporated, AbbVie Inc., Prestige Consumer Healthcare Inc., Spectra Vision Care, Théa Laboratories, Wellona Pharma, SAGER PHARMA, Maya Biotech Private Limited, EYERIS VISIONCARE Pvt. Ltd., Sylentis, Bayer AG, Zydus Group, Amneal Pharmaceuticals LLC, OASIS Medical, Similasan Corporation, Alcon and Santen Pharmaceutical Co., Ltd.
Research Methodology
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. En outre, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. La principale méthodologie de recherche utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement de l'entreprise, l'analyse des parts de marché des entreprises, les normes de mesure, l'Asie-Pacifique par rapport aux régions et l'analyse des parts des fournisseurs. Veuillez demander un appel d'analyste en cas de demande de renseignements supplémentaires.
Personnalisation disponible
Data Bridge Market Research est un leader dans la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, le marché des produits remis à neuf et une analyse de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TREATMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END-USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 EPIDERMIOLOGY
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES
4.4 PIPELINE ANALYSIS FOR THE ASIA PACIFIC PINGUECULUM DRUGS MARKET
4.5 INDUSTRIAL INSIGHTS:
4.6 CONCLUSION:
5 ASIA PACIFIC PINGUECULUM DRUGS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS
6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT
6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES
6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT
6.2 RESTRAINTS
6.2.1 STRINGENT RULES & REGULATIONS
6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT
6.3 OPPORTUNITIES
6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES
6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME
6.4 CHALLENGES
6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS
6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS
7 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS
7.2.1 DEMULCENT
7.2.2 EMOLLIENTS
7.3 STEROID EYE DROPS
7.3.1 KETONE STEROIDS
7.3.1.1 PREDNISOLONE
7.3.1.2 DEXAMETHASONE
7.3.1.3 FLUROMETHOLONE
7.3.1.4 MEDRYSONE
7.3.1.5 RIMEXOLONE
7.3.1.6 OTHERS
7.3.2 ESTER STEROID (LOTERPREDNOL)
7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS
7.5 OTHERS
8 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION
8.1 OVERVIEW
8.2 EYE DROPS
8.2.1 EYE DROPS WITH PRESERVATIVES
8.2.2 PRESERVATIVE-FREE EYE DROPS
8.3 EYE OINTMENTS
8.3.1 WITH PRESERVATIVES
8.3.2 PRESERVATIVE-FREE
8.3.3 OTHERS
8.4 OTHERS
9 ASIA PACIFIC PINGUECULUM DRUGS MARKET, MODE OF PURCHASE
9.1 OVERVIEW
9.2 PRESCRIPTION
9.3 OVER THE COUNTER (OTC)
10 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE
10.1 OVERVIEW
10.2 BRANDED
10.3 GENERICS
11 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE
11.1 OVERVIEW
11.2 GERIATRIC
11.2.1 MALE
11.2.2 FEMALE
11.3 ADULTS
11.3.1 MALE
11.3.2 FEMALE
12 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 SPECIALTY CLINICS
12.4 HOME HEALTHCARE
12.5 OTHERS
13 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 RETAIL PHARMACIES
13.3 HOSPITAL PHARMACIES
13.4 ONLINE PHARMACIES
13.5 OTHERS
14 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 INDIA
14.1.3 JAPAN
14.1.4 INDONESIA
14.1.5 SOUTH KOREA
14.1.6 AUSTRALIA
14.1.7 THAILAND
14.1.8 VIETNAM
14.1.9 PHILIPPINES
14.1.10 MALAYSIA
14.1.11 SINGAPORE
14.1.12 REST OF ASIA- PACIFIC
15 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ALCON INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 ABBVIE INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 BAUSCH & LOMB INCORPORATED
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 BAYER AG
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 JOHNSON & JOHNSON VISION CARE, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 AKORN OPERATING COMPANY LLC
17.6.1 COMPANY SNAPSHOT
17.6.2 . PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 AMNEAL PHARMACEUTICALS LLC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 EYERIS VISIONCARE PVT. LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 LABORATOIRES THÉA
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 MAYA BIOTECH PRIVATE LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 NOVARTIS AG
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 OASIS MEDICAL, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PRESTIGE CONSUMER HEALTHCARE, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 SAGER PHARMA
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 SANTEN PHARMACEUTICAL CO., LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SIMILASAN CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 SPECTRA VISION CARE
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 SYLENTIS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 WELLONA PHARMA
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 ZYDUS GROUP
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
Liste des tableaux
TABLE 1 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 2 ASIA PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 37 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 38 ASIA-PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 ASIA-PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 43 ASIA-PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 44 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 47 ASIA-PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 48 ASIA-PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 49 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 CHINA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 52 CHINA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 CHINA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 CHINA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 CHINA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 56 CHINA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 57 CHINA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 58 CHINA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 59 CHINA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 60 CHINA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 61 CHINA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 62 CHINA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 63 CHINA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 64 CHINA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 65 INDIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 66 INDIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 INDIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 INDIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 INDIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 70 INDIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 71 INDIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 72 INDIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 73 INDIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 74 INDIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 75 INDIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 76 INDIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 77 INDIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 78 INDIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 79 JAPAN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 80 JAPAN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 81 JAPAN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 82 JAPAN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 83 JAPAN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 84 JAPAN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 85 JAPAN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 86 JAPAN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 87 JAPAN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 88 JAPAN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 89 JAPAN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 90 JAPAN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 91 JAPAN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 92 JAPAN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 93 INDONESIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 94 INDONESIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 95 INDONESIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 96 INDONESIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 97 INDONESIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 98 INDONESIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 99 INDONESIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 100 INDONESIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 101 INDONESIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 102 INDONESIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 103 INDONESIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 104 INDONESIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 105 INDONESIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 106 INDONESIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 107 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 108 SOUTH KOREA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 109 SOUTH KOREA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 110 SOUTH KOREA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 111 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 112 SOUTH KOREA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 113 SOUTH KOREA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 114 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 115 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 116 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 117 SOUTH KOREA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 118 SOUTH KOREA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 119 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 120 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 121 AUSTRALIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 122 AUSTRALIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 AUSTRALIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 AUSTRALIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 AUSTRALIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 126 AUSTRALIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 127 AUSTRALIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 128 AUSTRALIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 129 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 130 AUSTRALIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 131 AUSTRALIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 132 AUSTRALIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 133 AUSTRALIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 134 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 135 THAILAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 136 THAILAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 137 THAILAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 138 THAILAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 139 THAILAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 140 THAILAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 141 THAILAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 142 THAILAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 143 THAILAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 144 THAILAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 145 THAILAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 146 THAILAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 147 THAILAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 148 THAILAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 149 VIETNAM PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 150 VIETNAM ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 151 VIETNAM STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 152 VIETNAM KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 153 VIETNAM PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 154 VIETNAM EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 155 VIETNAM EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 156 VIETNAM PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 157 VIETNAM PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 158 VIETNAM PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 159 VIETNAM GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 160 VIETNAM ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 161 VIETNAM PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 162 VIETNAM PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 163 PHILIPPINES PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 164 PHILIPPINES ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 165 PHILIPPINES STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 166 PHILIPPINES KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 167 PHILIPPINES PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 168 PHILIPPINES EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 169 PHILIPPINES EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 170 PHILIPPINES PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 171 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 172 PHILIPPINES PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 173 PHILIPPINES GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 174 PHILIPPINES ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 175 PHILIPPINES PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 176 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 177 MALAYSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 178 MALAYSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 179 MALAYSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 180 MALAYSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 181 MALAYSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 182 MALAYSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 183 MALAYSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 184 MALAYSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 185 MALAYSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 186 MALAYSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 187 MALAYSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 188 MALAYSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 189 MALAYSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 190 MALAYSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 191 SINGAPORE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 192 SINGAPORE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 193 SINGAPORE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 194 SINGAPORE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 195 SINGAPORE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 196 SINGAPORE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 197 SINGAPORE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 198 SINGAPORE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 199 SINGAPORE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 200 SINGAPORE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 201 SINGAPORE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 202 SINGAPORE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 203 SINGAPORE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 204 SINGAPORE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 205 REST OF ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
Liste des figures
FIGURE 1 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC PINGUECULUM DRUGS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DBMR POSITION GRID
FIGURE 8 ASIA PACIFIC PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 ASIA PACIFIC PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID
FIGURE 10 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE ASIA PACIFIC PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029
FIGURE 12 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET FROM 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET
FIGURE 14 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021
FIGURE 15 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION)
FIGURE 16 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029)
FIGURE 17 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021
FIGURE 19 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION)
FIGURE 20 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029)
FIGURE 21 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021
FIGURE 23 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
FIGURE 24 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029)
FIGURE 25 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021
FIGURE 27 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION)
FIGURE 28 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029)
FIGURE 29 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021
FIGURE 31 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION)
FIGURE 32 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029)
FIGURE 33 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 34 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, 2021
FIGURE 35 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 36 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 37 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 39 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 40 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 41 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)
FIGURE 43 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)
FIGURE 44 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)
FIGURE 47 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
